NasdaqCM - Nasdaq Real Time Price USD
ENDRA Life Sciences Inc. (NDRA)
6.14
-1.05
(-14.65%)
At close: May 2 at 4:00:00 PM EDT
6.07
-0.07
(-1.22%)
After hours: May 2 at 6:22:38 PM EDT
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Alexander Y. Tokman | Acting CEO & Chairman | 398.03k | -- | 1962 |
| Mr. Richard Jacroux | CFO & Secretary | 241.48k | -- | 1968 |
| Mr. Michael Thornton Ph.D. | Chief Technology Officer | 222.08k | -- | 1968 |
| Dr. Jonathan Behr Ph.D. | Co-Founder | -- | -- | -- |
| Mr. Steve Freeman | Human Resources Leader | -- | -- | -- |
| Mr. Ziad Rouag | Head of Regulatory & Clinical Affairs | -- | -- | -- |
ENDRA Life Sciences Inc.
- Sector:
- Healthcare
- Industry: Diagnostics & Research
- Full Time Employees:
- 21
Description
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source comprising radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
Corporate Governance
ENDRA Life Sciences Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
May 12, 2025 at 10:59 AM UTC - May 16, 2025 at 12:00 PM UTC
ENDRA Life Sciences Inc. Earnings Date
Recent Events
Related Tickers
APDN Applied DNA Sciences, Inc.
0.8910
-2.09%
MYNZ Mainz Biomed N.V.
2.8450
-4.53%
PRPH ProPhase Labs, Inc.
0.3307
+2.45%
ISPC iSpecimen Inc.
1.2500
-1.57%
CHEK Check-Cap Ltd.
0.7601
-4.99%
NEO NeoGenomics, Inc.
7.70
+6.06%
TTOO T2 Biosystems, Inc.
0.1500
-4.70%
PRPO Precipio, Inc.
7.32
+17.65%
WGS GeneDx Holdings Corp.
67.23
+7.88%
XGN Exagen Inc.
6.02
-1.95%